Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Interference01:23

RNA Interference

24.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.3K
Experimental RNAi02:15

Experimental RNAi

6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

Blood cancer journal·2026
Same author

Low-Cycle Fatigue Behavior and Microstructural Damage Mechanisms of 316L Austenitic Stainless Steel in Cryogenic Environments.

Materials (Basel, Switzerland)·2026
Same author

A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

Blood cancer discovery·2026
Same author

Correction to "Microchip-Based Structure Determination of Disease-Relevant p53".

Analytical chemistry·2026
Same author

Oral connexin43-peptide-loaded milk extracellular vesicles mitigate lethal radiation injury while preserving tumour radiosensitivity.

Cancer letters·2026
Same author

Pathogenesis of diffuse large B cell lymphoma proteogenotypes.

Cancer cell·2026

Related Experiment Video

Updated: Apr 26, 2026

RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells
08:20

RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells

Published on: August 25, 2010

11.1K

A diphtheria toxin negative selection in RNA interference screening.

Zhi Sheng1, Susan F Murphy, Sujuan Guo

  • 1Virginia Tech Carilion Research Institute, 2 Riverside Circle, Roanoke, VA, 24016, USA, zhisheng@vtc.vt.edu.

Methods in Molecular Biology (Clifton, N.J.)
|July 18, 2014
PubMed
Summary

This study introduces a novel diphtheria toxin negative selection method for RNA interference (RNAi) screening. This approach overcomes cell death issues, enabling the identification of essential cancer survival genes and potential therapeutic targets.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

8.8K
RNAi Screening to Identify Postembryonic Phenotypes in C. elegans
09:40

RNAi Screening to Identify Postembryonic Phenotypes in C. elegans

Published on: February 13, 2012

16.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells
08:20

RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells

Published on: August 25, 2010

11.1K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

8.8K
RNAi Screening to Identify Postembryonic Phenotypes in C. elegans
09:40

RNAi Screening to Identify Postembryonic Phenotypes in C. elegans

Published on: February 13, 2012

16.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • RNA interference (RNAi) screening is vital for cancer research and drug target discovery.
  • Identifying essential survival genes via RNAi is challenging due to cell death upon knockdown.
  • Targeting genes crucial for cancer progression is a key therapeutic strategy.

Purpose of the Study:

  • To develop a negative selection method for RNAi screening that circumvents cell death.
  • To identify genes essential for cancer cell survival and potential therapeutic targets.
  • To enable RNAi screening for genes controlling cell survival in malignant glioma.

Main Methods:

  • A diphtheria toxin (DT) negative selection strategy was employed.
  • A construct for human diphtheria toxin receptor (DTR) driven by the mouse Atf5 promoter was created.
  • A DT-sensitive mouse malignant glioma cell line overexpressing DTR was established for RNAi screening.

Main Results:

  • The developed method successfully enabled RNAi screening in DT-sensitive cells.
  • Genes that activate Atf5 expression, crucial for glioma survival, were identified.
  • The negative selection approach proved effective in identifying genes controlling cell survival.

Conclusions:

  • The diphtheria toxin negative selection method facilitates RNAi screening for essential cancer survival genes.
  • This technique offers a powerful approach for discovering therapeutic targets in cancer and other diseases.
  • The method overcomes limitations of traditional RNAi screening, enabling broader applications in disease research.